Researcher at The Cancer Institute of New Jersey says Greater Efforts are Needed to Promote Screening
New Brunswick, N.J.– Among people over 50, those who did not finish high school or have not recently had common cancer screenings such as a mammogram, prostate-specific antigen (PSA) test or colorectal cancer screening, are also less likely to be screened for skin cancer. This finding appears in a new study by an investigator at...
TUSTIN, CA--(Marketwire - April 14, 2010) - US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the Journal of Immunoassay and Immunochemistry (April 2010, Volume 31) has published a...
Pfizer Oncology To Present Over 30 Abstracts On Pre-Clinical And Clinical Research At The American Association For Cancer Research Annual Meeting
Market Watch
April 14, 2010, 8:00 a.m. EDT
Source: Business Wire
First-ever Data Presentation of PF-04691502, Pfizer's Dual PI3K/mTOR Inhibitor
NEW YORK, Apr 14, 2010 (BUSINESS WIRE) -- Pfizer Oncology announced today that it will present new data from the company's pipeline, including two novel,...
ST. JOHN'S, N.L. — Thirty years after Terry Fox dipped his artificial leg in the frigid North Atlantic his fierce fight against cancer is still a driving force in the quest for a cure.
Family and friends launched a research effort Monday to mark three decades since Fox began his Marathon of Hope in St. John's.
The Terry Fox Research Institute's Atlantic Node would unite cancer-care experts in Atlantic...
Amgen Highlights Biomarker and Preclinical Data to be Presented at American Association for Cancer Research (AACR) Annual Meeting
Key RANK Ligand Preclinical Data and Vectibix Biomarker Data Will Be Presented
THOUSAND OAKS, Calif., April 12 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that results from several preclinical studies investigating potential new cancer agents and a comprehensive biomarker analysis will be presented at the American Association...
